Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect.

Li X, Huang J, Kawamura A, Funakoshi R, Porcelli SA, Tsuji M.

Vaccine. 2017 May 31;35(24):3171-3177. doi: 10.1016/j.vaccine.2017.04.077. Epub 2017 May 5.

PMID:
28483194
2.

A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice.

Li X, Huang J, Kaneko I, Zhang M, Iwanaga S, Yuda M, Tsuji M.

Expert Rev Vaccines. 2017 Jan;16(1):73-80. Epub 2016 Nov 16.

PMID:
27801602
4.

Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B.

Rampuria P, Lang GA, Devera TS, Gilmore C, Ballard JD, Lang ML.

J Leukoc Biol. 2017 Feb;101(2):567-576. doi: 10.1189/jlb.4A0616-271R. Epub 2016 Aug 26.

PMID:
27566831
5.

Invariant natural killer T cells: front line fighters in the war against pathogenic microbes.

Crosby CM, Kronenberg M.

Immunogenetics. 2016 Aug;68(8):639-48. doi: 10.1007/s00251-016-0933-y. Epub 2016 Jul 1. Review.

6.

Mucosal adjuvants: Opportunities and challenges.

Zeng L.

Hum Vaccin Immunother. 2016 Sep;12(9):2456-8. doi: 10.1080/21645515.2016.1181236. Epub 2016 May 9.

7.

Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.

Mor V, Farnoud AM, Singh A, Rella A, Tanno H, Ishii K, Kawakami K, Sato T, Del Poeta M.

PLoS One. 2016 Apr 15;11(4):e0153853. doi: 10.1371/journal.pone.0153853. eCollection 2016.

8.

α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant.

Artiaga BL, Yang G, Hackmann TJ, Liu Q, Richt JA, Salek-Ardakani S, Castleman WL, Lednicky JA, Driver JP.

Sci Rep. 2016 Mar 23;6:23593. doi: 10.1038/srep23593.

9.

The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation.

Gottschalk C, Mettke E, Kurts C.

Front Immunol. 2015 Jul 28;6:379. doi: 10.3389/fimmu.2015.00379. eCollection 2015. Review.

10.

Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.

Li X, Kawamura A, Andrews CD, Miller JL, Wu D, Tsao T, Zhang M, Oren D, Padte NN, Porcelli SA, Wong CH, Kappe SH, Ho DD, Tsuji M.

J Immunol. 2015 Sep 15;195(6):2710-21. doi: 10.4049/jimmunol.1403017. Epub 2015 Aug 7.

11.

Regulation of NKT Cell Localization in Homeostasis and Infection.

Slauenwhite D, Johnston B.

Front Immunol. 2015 May 27;6:255. doi: 10.3389/fimmu.2015.00255. eCollection 2015. Review.

12.

Synthesis and Biological Activities of 5-Thio-α-GalCers.

Bi J, Wang J, Zhou K, Wang Y, Fang M, Du Y.

ACS Med Chem Lett. 2015 Feb 11;6(4):476-80. doi: 10.1021/acsmedchemlett.5b00046. eCollection 2015 Apr 9.

13.

CD1d-dependent expansion of NKT follicular helper cells in vivo and in vitro is a product of cellular proliferation and differentiation.

Rampuria P, Lang ML.

Int Immunol. 2015 May;27(5):253-63. doi: 10.1093/intimm/dxv007. Epub 2015 Feb 20.

14.

Sublingual injection of microparticles containing glycolipid ligands for NKT cells and subunit vaccines induces antibody responses in oral cavity.

DeLyria ES, Zhou D, Lee JS, Singh S, Song W, Li F, Sun Q, Lu H, Wu J, Qiao Q, Hu Y, Zhang G, Li C, Sastry KJ, Shen H.

Carbohydr Res. 2015 Mar 20;405:87-92. doi: 10.1016/j.carres.2014.11.007. Epub 2014 Dec 3.

15.

Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Nizard M, Diniz MO, Roussel H, Tran T, Ferreira LC, Badoual C, Tartour E.

Hum Vaccin Immunother. 2014;10(8):2175-87. doi: 10.4161/hv.29269. Review.

16.

The dichotomy of pathogens and allergens in vaccination approaches.

Baird FJ, Lopata AL.

Front Microbiol. 2014 Jul 16;5:365. doi: 10.3389/fmicb.2014.00365. eCollection 2014. Review.

17.

Optimizing NKT cell ligands as vaccine adjuvants.

Carreño LJ, Kharkwal SS, Porcelli SA.

Immunotherapy. 2014;6(3):309-20. doi: 10.2217/imt.13.175. Review.

18.

Invariant NKT cells provide innate and adaptive help for B cells.

Vomhof-DeKrey EE, Yates J, Leadbetter EA.

Curr Opin Immunol. 2014 Jun;28:12-7. doi: 10.1016/j.coi.2014.01.007. Epub 2014 Feb 8. Review.

19.

Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.

Amador-Molina A, Hernández-Valencia JF, Lamoyi E, Contreras-Paredes A, Lizano M.

Viruses. 2013 Oct 28;5(11):2624-42. doi: 10.3390/v5112624. Review.

20.

Natural killer T cell based Immunotherapy.

Subrahmanyam PB, Sun W, East JE, Li J, Webb TJ.

J Vaccines Vaccin. 2012 Aug 23;3:144.

Supplemental Content

Support Center